Compare PBT & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBT | QSI |
|---|---|---|
| Founded | 1980 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 799.8M | 273.7M |
| IPO Year | N/A | N/A |
| Metric | PBT | QSI |
|---|---|---|
| Price | $17.63 | $1.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.63 |
| AVG Volume (30 Days) | 66.2K | ★ 4.8M |
| Earning Date | 03-13-2026 | 11-05-2025 |
| Dividend Yield | ★ 1.74% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $17,266,423.00 | $3,177,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $159.68 |
| P/E Ratio | $53.63 | ★ N/A |
| Revenue Growth | N/A | ★ 40.20 |
| 52 Week Low | $8.01 | $0.95 |
| 52 Week High | $20.46 | $5.77 |
| Indicator | PBT | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 37.80 |
| Support Level | $16.78 | $1.07 |
| Resistance Level | $17.33 | $1.33 |
| Average True Range (ATR) | 0.61 | 0.08 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 77.97 | 22.22 |
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.